Ph.D, served as Editor-in-Chief of Science (2009-2013) and as one of President Obama’s first three Science Envoys (2009-2011). Alberts is also Professor Emeritus in the Department of Biochemistry and Biophysics at the University of California, San Francisco, to which he returned after serving two six-year terms as the president of the National Academy of Sciences (NAS). During his tenure at the NAS, Alberts was instrumental in developing the landmark National Science Education standards for school systems in the USA. Alberts is also one of the authors of The Molecular Biology of the Cell, a preeminent textbook in the field. He currently serves on the advisory boards of more than 25 non-profit institutions.
, Ph.D., was Academic Coordinator at the Science and Health Education Partnership (SEP) in UCSF from 1998 to 2013. Her professional experience includes: teaching students, community college, graduate and professional students, and teachers; leading professional development for teachers and scientists in areas of science inquiry and teaching strategies in science. She currently serves on the University Community Partnership Program. Prior to joining SEP, Caldera was a research scientist at UCSF in the Pharmaceutical Chemistry and Pharmacology departments where she collaborated on projects of drug toxicology and rational drug design. She received her Ph.D. in Organic Chemistry from New York University.
, MD, MPH, is Chancellor of the University of California, San Francisco. She previously served as president of product development at Genentech. During her time at Genentech, several of the company’s patient therapeutics (Lucentis, Avastin, Herceptin, Tarceva, Rituxan and Xolair) were approved by the U.S. FDA, and the company became USA’s No. 1 producer of anti-cancer drug treatments. In November 2009, Forbes magazine named Desmond-Hellmann as one of the world’s seven most “powerful innovators” calling her “a hero to legions of cancer patients”. She also has served as adjunct professor of epidemiology and biostatistics at UCSF.
is Past President of the Chile-California Council. He lives in San Francisco and in Chile. As a wine entrepreneur he has created and managed wine companies in Chile, Argentina, Spain, France, Italy, Germany, New Zealand, and California. Today, the family company, Huneeus Vintners, is comprised of several innovative vineyards: Quintessa, Faust and Illumination, in Napa Valley; Flowers, in Sonoma coast; and Veramonte, Neyen, and Primus, in Chile. He is recipient of Chile’s highest civilian award, Servicios Meritorios a la República medal, and the Distinguished Service Award from the Wine Spectator magazine.
has been President of Foothill College in Los Altos Hills, California since 2007. She has worked as a higher education administrator since 1977. She serves on advisory boards for the Center for the Future of Teaching and Learning and the Doctorate in Education Program at San Francisco State University. She serves on the Board of Directors for the American Council of Education. In 2011, she also participated on the Working Group that produced Report to the President, Engage to Excel: Producing One Million additional College Graduates with Degrees in Science, Technology, Engineering, and Mathematics. On March 23, 2012, Science magazine published her editorial entitled “America’s Community Colleges” with an accompanying podcast that highlights the science initiatives at
Regis B. Kelly
, Ph.D., is the Director of QB3, one of four California Institutes for Science and Innovation, created by the California Legislature to strengthen the academic foundation of its technology-based industries. QB3 is an innovation center made up of over 200 quantitative biologists working at the interface of the physical and biological sciences and a team of professionals converting its discoveries into practical benefits for society. Kelly served as Executive Vice Chancellor at the University of California in San Francisco (200-2004), as Chair of the Department of Biochemistry and Biophysics (1995-2000); and as the Director of the Hormone Research Institute at UCSF. He has published in the areas of cell and neurobiology.
Edward E. Penhoet
, Ph.D. serves as a director of Alta Partners, a venture capital firm, and is a member of the President Obama Council of Advisors for Science and Technology. Penhoet served as the Dean of the School of Public Health at the University of California, Berkeley
(1998-2002). Hewas a co-founder of Chiron Corporation, a biotechnology company, where he served as President, Chief Executive Officer and a director (1981-1998). He is a member of the
Institute of Medicine of the National Academy of Sciences and The American Academy of Arts & Sciences and serves, or has served, as a director several biotechnology companies. Dr. Penhoet received a Ph.D. in Biochemistry from the University of Washington.
Ph.D., is Chairman and CEO of Synergenics, LLC, which operates a consortium of commonly-owned but independent biotech companies offering an innovative and cost-effective approach to start-ups in the life sciences industry. He is also Herzstein Professor of Biochemistry Emeritus at the University of California, San Francisco. Rutter previously served as a co-founder and Chairman of Chiron Corporation and member of the Board of Director of Ciba-Greigy/Novartis. Rutter was chairman of the Department of Biochemistry and Biophysics at the University of California, San Francisco. Rutter was elected to the U.S. National Academic of Sciences and American Academy of Arts and Sciences more than two decades ago.
, M.D., is currently the Director of the Prostate Cancer Program in the Comprehensive Cancer Center at the University of California, San Francisco, and the Clinical Director of the California Institute for Quantitative Biomedical Research (QB3), San Francisco. Currently, he serves on the Steering Committee for the Multiple Myeloma Translational Initiative within the Hematologic Malignancy Program. Shuman uses his scientific and clinical experience to stimulate and accelerate interdisciplinary research between basic and disease-based scientists and clinical investigators. He holds a degree in Biology from University of Pennsylvania, Philadelphia, and Medicine from Thomas Jefferson Medical College Philadelphia.
, Ph.D., is a Professor in the Department of Biochemistry & Biophysics at the University of California, San Francisco, where he has served as Director of the Cell Biology Program. He is also an Investigator of the Howard Hughes Medical Institute. Research in Dr. Walter’s lab focuses on basic questions in cell biology as how proteins become properly localized within a cell, how cell membranes fuse, and how cells maintain the abundance of organelles in proper balance. His PhD research was conducted in the laboratory of Dr. Günter Blobel where he purified the signal recognition particle and characterized its function.Walter is also one of the authors of The Molecular Biology of the Cell, a preeminent textbook in the field.